HLA transgenic mice as humanized mouse models of disease and immunity.
Taneja
V
V
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.
David
C S
CS
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology; D004195:Disease Models, Animal; D006680:HLA Antigens / Q000235:genetics* / Q000276:immunology; D006683:HLA-DQ Antigens / Q000235:genetics / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000235:genetics / Q000276:immunology; D007154:Immune System Diseases / Q000235:genetics* / Q000276:immunology; D007109:Immunity / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D009103:Multiple Sclerosis / Q000235:genetics / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000235:genetics / Q000276:immunology; D019076:Transgenes; D014612:Vaccines / Q000235:genetics / Q000276:immunology
D006680:HLA Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D014612:Vaccines